Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PURE FIST: UGT1A1-Guided Irinotecan Escalation in mCRC
NCT02256800Completed
- Start
- Aug 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of irinotecan in metastatic colorectal cancer (mCRC). Started Aug 2014; status: completed.
02
Drugs
irinotecan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02256800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256800.